Drug Development

“The assessment of lung function endpoints used in preclinical drug testing may hold the key to translation of drug efficacy from mouse to man.”

– Dr. Jonathan Phillips, Amgen

Over the years, the flexiVent has become the industry standard in terms of preclinical lung function measurements and has proven to be an invaluable tool in early drug development, as it goes beyond traditional resistance and compliance measurements. The flexiVent has been used successfully and efficiently during the development of novel drug models, in gaining novel insights into the mechanism of action of drugs, in pre-clinical drug testing, and bench-marking marketed drugs in murine models.